| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	Barclays analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight and raises the price target from $2...
																	Privia Health (PRVA) to acquire Evolent Health's (EVH) ACO business for $100M, expanding its value-based care footprint.
																	
																	Stephens & Co. analyst Jeff Garro reiterates Privia Health Gr (NASDAQ:PRVA) with a Overweight and maintains $32 price ta...
																	
																	
																	Stephens & Co. analyst Jeff Garro reiterates Privia Health Gr (NASDAQ:PRVA) with a Overweight and maintains $32 price ta...
																	JMP Securities analyst David M. Scharf maintains Privia Health Gr (NASDAQ:PRVA) with a Market Outperform and raises the pric...